"Neurodevelopmental Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-V).
- Neurodevelopmental Disorders
- Disorder, Neurodevelopmental
- Disorders, Neurodevelopmental
- Neurodevelopmental Disorder
- Disorders Usually Diagnosed in Infancy, Childhood or Adolescence
- Child Mental Disorders
- Child Mental Disorder
- Disorder, Child Mental
- Disorders, Child Mental
- Mental Disorder, Child
- Mental Disorders, Child
- Mental Disorders Diagnosed in Childhood
Below are MeSH descriptors whose meaning is more general than "Neurodevelopmental Disorders".
Below are MeSH descriptors whose meaning is more specific than "Neurodevelopmental Disorders".
This graph shows the total number of publications written about "Neurodevelopmental Disorders" by people in this website by year, and whether "Neurodevelopmental Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Neurodevelopmental Disorders" by people in Profiles.
Biallelic variants in KARS1 are associated with neurodevelopmental disorders and hearing loss recapitulated by the knockout zebrafish. Genet Med. 2021 10; 23(10):1933-1943.
Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia. Genet Med. 2021 05; 23(5):881-887.
De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy. Genet Med. 2021 04; 23(4):653-660.
Effect of Maternal Docosahexaenoic Acid (DHA) Supplementation on Offspring Neurodevelopment at 12 Months in India: A Randomized Controlled Trial. Nutrients. 2020 Oct 03; 12(10).
Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders. Nat Commun. 2020 07 03; 11(1):3358.
Growth, Body Composition, and Neurodevelopmental Outcomes at 2 Years Among Preterm Infants Fed an Exclusive Human Milk Diet in the Neonatal Intensive Care Unit: A Pilot Study. Breastfeed Med. 2020 05; 15(5):304-311.
De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders. Am J Hum Genet. 2020 03 05; 106(3):405-411.
Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana. J Acquir Immune Defic Syndr. 2018 11 01; 79(3):e93-e100.
The impact of DocosaHexaenoic Acid supplementation during pregnancy and lactation on Neurodevelopment of the offspring in India (DHANI): trial protocol. BMC Pediatr. 2018 08 04; 18(1):261.
Early low-dose hydrocortisone: is the neurodevelopment affected? J Perinatol. 2018 06; 38(6):636-638.